相关实验视频

Updated: Jun 27, 2025

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins

Published on: June 14, 2018

用于癌症免疫治疗的基因编辑级联纳米酶

Jing Zhang^1,2, Yuanwei Pan², Lujie Liu²

¹Key Laboratory of Artificial Micro- and Nano-Structures of Ministry of Education, School of Physics and Technology, Wuhan University, Wuhan 430072, China.

|May 2, 2024

概括

这项研究引入了一种新型纳米酶 (gCM@MnAu),通过诱导免疫细胞死亡和激活STING通路来增强癌症免疫疗法. 这种方法可以提高T细胞对瘤的反应,改善治疗结果.

科学领域:

生物医学工程生物医学工程
免疫学免疫学免疫学
纳米技术纳米技术

背景情况:

免疫检查点阻塞 (ICB) 在癌症治疗中表现有前途,但由于树突细胞 (DC) 活化不良和细胞毒性T淋巴细胞 (CTL) 透而受到限制.
诱导免疫细胞死亡 (ICD) 可以增强DC成熟和T细胞免疫力,但固体瘤往往表现出较低的ICD水平,限制了持久的抗瘤疗效.

研究的目的:

开发一种基因编辑的纳米酶 (gCM@MnAu),通过诱导ICD和激活干扰素基因刺激器 (STING) 途径来增强癌症免疫疗法.
研究Chim@MnAu与ICB的协同作用,以改善抗瘤反应.

主要方法:

一种经过基因编辑的细胞膜涂层级联纳米酶 (gCM@MnAu) 旨在在瘤微环境 (TME) 中产生基基 (•OH) 以进行增强化学动力学疗法 (CDT) 和ICD诱导.
释放的Mn2+离子被用来激活STING通路,促进DC成熟.
与PD-1/PD-L1阻断相结合的Chim@MnAu的疗效在乳腺癌和肺转移小鼠模型中进行了评估.

主要成果:

基M@MnAu纳米酶在TME中启动了级联反应,产生OH以促进CDT和ICD.
释放的Mn2+激活了STING通路,进一步增强了DC成熟和T细胞初始化.
结合疗法显示出协同效应,显著改善抗瘤反应,并延长小鼠模型的存活时间.
纳米酶策略有效地增强了DC介导的对抗免疫性较差的固体瘤的交叉启动.

结论:

基因编辑的纳米酶通过克服当前治疗方法的局限性,为癌症免疫治疗提供了一个有希望的战略.
开发的Chim@MnAu纳米酶有效诱导ICD,激活STING通路,并与ICB协同产生强大的全身抗瘤免疫力.
这种方法有可能治疗免疫性较差的固体瘤并改善患者的存活率.

关键词:

在cGAS-STING路径中.癌症免疫疗法免疫疗法级联的纳米酶级联.基因工程是基因工程的重要组成部分.免疫激活系统的激活免疫性细胞死亡免疫性细胞死亡

更多相关视频

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...